Silverfin false false 31/10/2025 01/11/2024 31/10/2025 J Arthurworrey 14/02/2025 31/10/2024 E Francis 31/10/2024 C Oliver 31/10/2024 13 July 2026 The principle activity of the Company during the year was that of GP locum services. 16052747 2025-10-31 16052747 bus:Director1 2025-10-31 16052747 bus:Director2 2025-10-31 16052747 bus:Director3 2025-10-31 16052747 core:CurrentFinancialInstruments 2025-10-31 16052747 core:ShareCapital 2025-10-31 16052747 core:RetainedEarningsAccumulatedLosses 2025-10-31 16052747 bus:OrdinaryShareClass1 2025-10-31 16052747 bus:OrdinaryShareClass2 2025-10-31 16052747 bus:OrdinaryShareClass3 2025-10-31 16052747 2024-11-01 2025-10-31 16052747 bus:FilletedAccounts 2024-11-01 2025-10-31 16052747 bus:SmallEntities 2024-11-01 2025-10-31 16052747 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 16052747 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 16052747 bus:Director1 2024-11-01 2025-10-31 16052747 bus:Director2 2024-11-01 2025-10-31 16052747 bus:Director3 2024-11-01 2025-10-31 16052747 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 16052747 bus:OrdinaryShareClass2 2024-11-01 2025-10-31 16052747 bus:OrdinaryShareClass3 2024-11-01 2025-10-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 16052747 (England and Wales)

CMEF MEDICAL LIMITED

Unaudited Financial Statements
For the financial year ended 31 October 2025
Pages for filing with the registrar

CMEF MEDICAL LIMITED

Unaudited Financial Statements

For the financial year ended 31 October 2025

Contents

CMEF MEDICAL LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 October 2025
CMEF MEDICAL LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 October 2025
Note 2025
£
Current assets
Debtors 3 1,972
Cash at bank and in hand 7,930
9,902
Creditors: amounts falling due within one year 4 ( 11,940)
Net current liabilities (2,038)
Total assets less current liabilities (2,038)
Net liabilities ( 2,038)
Capital and reserves
Called-up share capital 5 10
Profit and loss account ( 2,048 )
Total shareholders' deficit ( 2,038)

For the financial year ending 31 October 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of CMEF Medical Limited (registered number: 16052747) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

E Francis
Director

13 July 2026

CMEF MEDICAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 October 2025
CMEF MEDICAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 October 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year, unless otherwise stated.

General information and basis of accounting

CMEF Medical Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 1 The Atrium Phoenix Square, Wyncolls Road, Colchester, CO4 9AS, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Statement of Financial Position date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Statement of Financial Position date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Interest income

Interest income is recognised in the profit or loss using the effective interest method.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2025
Number
Monthly average number of persons employed by the Company during the year, including directors 3

3. Debtors

2025
£
Trade debtors 1,972

4. Creditors: amounts falling due within one year

2025
£
Amounts owed to directors 4,962
Accruals 1,800
Taxation and social security 5,178
11,940

5. Called-up share capital

2025
£
Allotted, called-up and fully-paid
3 A ordinary shares of £ 1.00 each 3
3 B ordinary shares of £ 1.00 each 3
4 C ordinary shares of £ 1.00 each 4
10

6. Related party transactions

Transactions with the entity's directors

2025
£
Amounts owed to directors 4,962